Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP379401.RA0f_36LyVJFhtEns6R91zWxv-Coqwhe9FnzPR0wCNFv4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP379401.RA0f_36LyVJFhtEns6R91zWxv-Coqwhe9FnzPR0wCNFv4130_assertion type Assertion NP379401.RA0f_36LyVJFhtEns6R91zWxv-Coqwhe9FnzPR0wCNFv4130_head.
- NP379401.RA0f_36LyVJFhtEns6R91zWxv-Coqwhe9FnzPR0wCNFv4130_assertion description "[One group of potential therapeutic agents for asthma are inhibitors of cyclic AMP-specific phosphodiesterase (PDE), of which theophylline may be considered a prototype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379401.RA0f_36LyVJFhtEns6R91zWxv-Coqwhe9FnzPR0wCNFv4130_provenance.
- NP379401.RA0f_36LyVJFhtEns6R91zWxv-Coqwhe9FnzPR0wCNFv4130_assertion evidence source_evidence_literature NP379401.RA0f_36LyVJFhtEns6R91zWxv-Coqwhe9FnzPR0wCNFv4130_provenance.
- NP379401.RA0f_36LyVJFhtEns6R91zWxv-Coqwhe9FnzPR0wCNFv4130_assertion SIO_000772 10730545 NP379401.RA0f_36LyVJFhtEns6R91zWxv-Coqwhe9FnzPR0wCNFv4130_provenance.
- NP379401.RA0f_36LyVJFhtEns6R91zWxv-Coqwhe9FnzPR0wCNFv4130_assertion wasDerivedFrom befree-20140225 NP379401.RA0f_36LyVJFhtEns6R91zWxv-Coqwhe9FnzPR0wCNFv4130_provenance.
- NP379401.RA0f_36LyVJFhtEns6R91zWxv-Coqwhe9FnzPR0wCNFv4130_assertion wasGeneratedBy ECO_0000203 NP379401.RA0f_36LyVJFhtEns6R91zWxv-Coqwhe9FnzPR0wCNFv4130_provenance.